Bio-Rad Laboratories Inc.
!%Bio-Rad Laboratories Inc.%! of Hercules,
Calif., has announced its purchase of !%2583%%Ciphergen Biosystems Inc.’s%! ProteinChip
Systems business and rights to the Fremont, Calif., company’s surface-enhanced
laser desorption/ionization technology. The cash transaction, totaling approximately
$20 million, gives the buyer manufacturing capability, selected product lines, intellectual
property and access to an expanded life sciences customer base, but leaves Ciphergen
rights to the diagnostics market. In a separate agreement, Bio-Rad has invested
$3 million in equity in the firm and has agreed to supply it with reagents and instruments.
LATEST NEWS
- Exail Signs LLNL Contract, Partners with Eelume
Apr 26, 2024
- Menlo Moves U.S. HQ: Week in Brief: 4/26/2024
Apr 26, 2024
- Optofluidics Platform Keys Label-, Amplification-Free Rapid Diagnostic Tool
Apr 25, 2024
- DUV Lasers Made with Nonlinear Crystals Enhance Lithography Performance
Apr 25, 2024
- Teledyne e2v, Airy3D Collaborate on 3D Vision Solutions
Apr 24, 2024
- One-Step Hologram Generation Speeds 3D Display Creation
Apr 24, 2024
- Innovation Award Winners for Laser Technology Honored in Aachen
Apr 23, 2024
- Intech 2024: AI Arrives on the Shop Floor
Apr 22, 2024